Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026)
Lensar's (LNSR) quarterly Asset Writedowns and Impairment came in at $15000.0 in Q1 2026, down 25.0% year-on-year from $20000.0 in Q1 2025, and up 130.0% on a QoQ basis from -$50000.0 in Q4 2025.
Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Lensar (LNSR) has 7 years of Asset Writedowns and Impairment data on file, last reported at $15000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 25.0% year-over-year to $15000.0 in Q1 2026; TTM through Mar 2026 was -$5000.0, a 100.13% decrease from a year earlier, with the FY2024 full-year figure at $94000.0, up 42.42% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $15000.0, up from -$50000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for LNSR reached as high as $3.7 million in Q2 2024 and fell as low as -$50000.0 in Q4 2025.
- Historically, Asset Writedowns and Impairment has averaged $245312.5 across 5 years, with a median of $14000.0 in 2023.
- Across the five-year window, Asset Writedowns and Impairment tumbled 250.0% in 2022 and soared 28584.62% in 2024, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $25000.0 in 2022, then surged by 84.0% to $46000.0 in 2023, then soared by 54.35% to $71000.0 in 2024, then sank by 170.42% to -$50000.0 in 2025, then soared by 130.0% to $15000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $15000.0 in Q1 2026, -$50000.0 in Q4 2025, and -$7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Jun 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |